Veracyte to Participate in the Credit Suisse 31st Annual Healthcare Conference

Rhea-AI Summary

Veracyte, Inc (Nasdaq: VCYT) announced that CEO Marc Stapley and CFO Rebecca Chambers will engage in a fireside chat at the Credit Suisse 31st Annual Healthcare Conference on November 8 at 1:25 p.m. ET. A live audio webcast will be accessible on Veracyte's website, with a replay available for 90 days post-event. Veracyte is a global diagnostics company focused on improving patient care through advanced diagnostic tests, helping avoid unnecessary procedures and expedite treatment.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate in a fireside chat at the Credit Suisse 31^st Annual Healthcare Conference on Tuesday, November 8, at 1:25 p.m. Eastern Time.

A live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions. Our growing menu of advanced diagnostic tests help patients avoid risky, costly procedures and interventions, and reduce time to appropriate treatment. In addition to making our tests available in the United States through our central laboratories, our exclusive license to our best-in-class diagnostics instrument (nCounter Analysis System) positions us to deliver our tests to patients worldwide through laboratories that can perform them locally. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

View source version on businesswire.com: https://www.businesswire.com/news/home/20221027006022/en/

Investors:

Shayla Gorman

Director, Investor Relations

investors@veracyte.com

619-393-1545

Media:

Tracy Morris

Vice President of Global Corporate Communications

tracy.morris@veracyte.com

650-380-4413

Source: Veracyte, Inc.

FAQ

When will Veracyte participate in the Credit Suisse Healthcare Conference?

Veracyte will participate in the Credit Suisse 31st Annual Healthcare Conference on November 8 at 1:25 p.m. Eastern Time.

Who from Veracyte will be speaking at the conference?

CEO Marc Stapley and CFO Rebecca Chambers will speak at the conference.

How can I access the Veracyte conference presentation?

The presentation can be accessed via Veracyte's investor relations website, which will host a live audio webcast.

Is there a replay available for the Veracyte presentation?

Yes, a replay of the Veracyte presentation will be available for 90 days after the live broadcast.

What is the focus of Veracyte as a company?

Veracyte focuses on improving patient care through advanced diagnostics that inform diagnosis and treatment decisions.